Compare Pfizer Inc (PFE) vs Vanguard S&P 500 ETF (VOO) Price & Performance

Pfizer IncTrade

Vanguard S&P 500 ETFTrade

Price performance (Past 24H)

Key statistics

Pfizer Inc vs Vanguard S&P 500 ETF — how do they compare? Pfizer Inc trades at $27.88 (market cap $158.39B), while Vanguard S&P 500 ETF trades at $702.3. The key difference: Pfizer Inc pays a 6.19% dividend while Vanguard S&P 500 ETF pays none, and Vanguard S&P 500 ETF is trading nearer its 52-week high, Pfizer Inc nearer its low. Which is the better fit depends on your goals.

	PFE	VOO
Market Cap	$158.39B	—
Volume	29,869,932	—
Sector	Health	Broad Market / Factor
52-Week High	$29.02	$714.90
52-Week Low	$23.60	$580.93
Enterprise Value	$209.89B	—
Dividend Yield	6.19%	—

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Pfizer Inc

Pfizer (PFE) trades at $27.78, down 2.36% today, with a consensus price target of $28.33 suggesting modest upside. The stock shows mixed technical signals with bullish moving averages but neutral oscillators. Recent earnings have consistently beaten expectations, though revenue declined from pandemic peaks. The company maintains strong cash flow generation and a solid dividend yield of approximately 3.1%.

Pfizer presents a value opportunity with reasonable valuation metrics and dividend stability, but faces headwinds from post-COVID revenue normalization and patent expirations. The company's pipeline progress in obesity and oncology could drive future growth, though execution risks remain. Analyst sentiment leans cautious with 59% hold ratings.

Vanguard S&P 500 ETF

VOO trades at $704.09, down 0.56% on the day, with a neutral technical signal and bullish moving averages. Support is firm near $701, while resistance sits at $707. The ETF remains a core S&P 500 holding, with recent news highlighting its tax efficiency versus gold ETFs and strong inflows amid record ETF launches in 2026.

Long-term outlook remains positive given historical S&P 500 performance, though risks include elevated market valuations and Fed policy uncertainty. The ETF offers broad market exposure, but investors face potential volatility from macroeconomic factors and high concentration in top AI-driven companies.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

PFE

Dividend Harvesting Portfolio hits 45.8% ROI with 7.83% yield, adding Pfizer and AGNC for income growth.Seeking Alpha · 1 day agoBullish Pfizer stock offers 13.8% upside plus a 5.91% dividend amid strong pipeline and cost savings.24/7 Wall Street · 2 days agoBullish View details →

VOO

Gold ETF gains taxed at 28%, nearly double S&P 500 ETF's 15% rate, costing investors thousands more.24/7 Wall Street · 12 hours agoBearish Four ETFs combine dividend income and total return to balance retirement income and growth risks.24/7 Wall Street · 1 day agoBullish S&P 500 moves with Fed rate hike odds; key 7620 level could signal buying opportunity after September CPI.Seeking Alpha · 2 days agoNeutral View details →

About Pfizer Inc

Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.

About Vanguard S&P 500 ETF

VOO is a foundational ETF that tracks the S&P 500 Index, providing exposure to 500 of the largest and most established companies in the United States. Renowned for its ultra-low expense ratio and tax efficiency, it serves as a core building block for long-term investors seeking to capture the total return of the U.S. large-cap market in a single, highly liquid vehicle.